share_log

TC BioPharm Shares Are Trading Higher After the Company Announced It Dosed 5 New Patients in Its ACHIEVE Phase 2b Trial.

TC BioPharm Shares Are Trading Higher After the Company Announced It Dosed 5 New Patients in Its ACHIEVE Phase 2b Trial.

TC BioPharm股價上漲,因爲該公司宣佈其ACHIEVE第20億期試驗給5名新患者注射了試藥。
Benzinga ·  09/03 10:08

TC BioPharm Shares Are Trading Higher After the Company Announced It Dosed 5 New Patients in Its ACHIEVE Phase 2b Trial.

TC Biopharm宣佈在ACHIEVE第20期試驗中爲5名新患者注射劑量後,該公司股價走高。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論